This book comprehensively addresses the very important area of interactions between chemotherapeutic drugs and radiation. It deals with each of the commonly used cytotoxic drugs and the potential for interaction with radiation based on stem cell kinetic and basic radiobiological principles. There is a vast amount of valuable information in this book and it represents an excellent reference textbook for workers involved in the area.
Commonly used cytotoxic drugs and their interactions with radiation are dealt with in separate chapters, with the information clearly and concisely presented. Therefore the data and references are easy to access, but not surprisingly, as many of the mechanisms involved in drug radiation interactions may be similar between drugs, there is a degree of repetition throughout the book. There is an impressive list of contributors to this textbook, and there is naturally some variability between chapters, but the editors have successfully managed to maintain format and style. I found three chapters particularly interesting. The first dealt with interactions involving adriamycin, actinomycin and radiation. The data are clearly presented dealing with effects on both normal and neoplastic cells, including drug resistant cells. There are many helpful graphs and the data is excellently summarised. The chapter dealing with 5-fluoro-uracil and radiation again contained clear, well presented figures, effectively summarising both pre-clinical and early clinical studies, pointing out the important areas for future research. Also, the chapter dealing with mitomycin C and radiation covered important areas such as the effect of hypoxia on sensitivity to both agents, and reviewed the limited clinical studies, pointing out the possibility of therapeutic gain with such a combination.
Obviously from the clinical stand-point the situation is disappointing, with the only significant positive interaction described relating to the combination of 5FU and radiation. The book identifies the difficulty of developing experimental models for the investigation of sensitive tumours where combination chemotherapy is normally used, where the benefit of combined modality treatment is likely to be maximal and where optimum scheduling of treatments may be critical.
On the other hand, there were areas where the book was disappointing. It is frequently inferred that current experimental model systems are inadequate and unlikely to have direct applicability to the clinical situation, with no clear ideas on how these models could be improved. The chapter dealing with resistance and future perspectives could have, in addition addressed the problem from a different stand-point, perhaps outlining how developments in molecular biology may help us to understand some of these complex interactions and hopefully offer some insight into the development of more rational and effective combined modality treatments in the future.
In conclusion, this book represents an excellent summary of our current knowledge on drug radiation interactions. As this topic is not extensively covered, I am sure it will be a valuable source of reference for many workers in the area, including radiobiologists, radiation oncologists and medical oncologists. This is a book of a meeting, but not the sort where there's the chummy discussion after each talk, with everyone being called by their first names. Rather, it's a collection of papers, carefully and somewhat formally written, mindful, perhaps, of the presence on the day of Princess Kikuko Takamatsu.
What I particularly like about this book is the chapter length -an average of five pages. I find this is just right for me to read in entirety a piece of work outside my own area of interest; any longer and I start skimming. There are two slightly longer chapters -the text of two lectures by the conference organisers, Alfred Knudson and Eric Stanbridge, but these are also eminently readable. Stanbridge reviews the evidence for the existence of tumour suppressor genes and Knudson provides a very useful catalogue of the cancers involving inherited predisposition and reviews what is known about the molecular genetics of each. Following the two lectures are six separate sections dealing with various aspects of oncogenes and tumour suppressor genes by many of the names which come to mind when these topics are mentioned. These chapters are all very well written: no evidence of hasty scrabbling together of a few lecture notes. However, this is probably reflected in the date of publication, more than a year after the Symposium. This of course means that not all the work is up to date, some areas obviously suffering more than others -the chapter on the genetic analysis of colon carcinoma, written before the isolation of the DCC, MCC and APC genes, being the prime example. However, the scope of the book is wide, so that being absolutely up to date is not its prime function.
There's a spate of books on tumour suppressor genes at the moment. Multi-author books such as this one have the advantage of each chapter being written by an expert and the possible disadvantage of not being completely comprehensive -and this is certainly true of this book, for example, the oncogene section does not have a chapter on ras.
Overall, one to advise the librarian to buy rather than to add to a personal collection.
